Cargando…

Phosphoinositide 3-Kinase Signaling Pathway in Pancreatic Ductal Adenocarcinoma Progression, Pathogenesis, and Therapeutics

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy characterized by its sudden manifestation, rapid progression, poor prognosis, and limited therapeutic options. Genetic alterations in key signaling pathways found in early pancreatic lesions are pivotal for the development and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murthy, Divya, Attri, Kuldeep S., Singh, Pankaj K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893816/ https://www.ncbi.nlm.nih.gov/pubmed/29670543 http://dx.doi.org/10.3389/fphys.2018.00335

Ejemplares similares

PTGES Expression Is Associated with Metabolic and Immune Reprogramming in Pancreatic Ductal Adenocarcinoma
por: Murthy, Divya, et al.
Publicado: (2023)

Emerging roles of long noncoding and circular RNAs in pancreatic ductal adenocarcinoma
por: Sato, Hiromichi, et al.
Publicado: (2022)

MSX2 in pancreatic tumor development and its clinical application for the diagnosis of pancreatic ductal adenocarcinoma
por: Satoh, Kennichi, et al.
Publicado: (2012)

Emerging Kinase Therapeutic Targets in Pancreatic Ductal Adenocarcinoma and Pancreatic Cancer Desmoplasia
por: Creeden, Justin F., et al.
Publicado: (2020)

MSP-RON Signaling Is Activated in the Transition From Pancreatic Intraepithelial Neoplasia (PanIN) to Pancreatic Ductal Adenocarcinoma (PDAC)
por: Li, Ce, et al.
Publicado: (2019)

The 3-Phosphoinositide-Dependent Protein Kinase 1 Inhibits Rod Photoreceptor Development
por: Xing, Tiaosi, et al.
Publicado: (2018)

Tri-2-Hydroxyarachidonein Induces Cytocidal Autophagy in Pancreatic Ductal Adenocarcinoma Cancer Cell Models
por: Fernández-Díaz, Javier, et al.
Publicado: (2022)

Apoptotic pathways in pancreatic ductal adenocarcinoma
por: Hamacher, Rainer, et al.
Publicado: (2008)

Genetic determinants and potential therapeutic targets for pancreatic adenocarcinoma
por: Reznik, Robert, et al.
Publicado: (2014)

Therapeutic Targeting of Autophagy in Pancreatic Ductal Adenocarcinoma
por: Raufi, Alexander G., et al.
Publicado: (2021)

Progress in Animal Models of Pancreatic Ductal Adenocarcinoma
por: Kong, Kaiwen, et al.
Publicado: (2020)

Extensive protein S-nitrosylation associated with human pancreatic ductal adenocarcinoma pathogenesis
por: Tan, Chaochao, et al.
Publicado: (2019)

Targeting PI3K Pathway in Pancreatic Ductal Adenocarcinoma: Rationale and Progress
por: Mehra, Siddharth, et al.
Publicado: (2021)

From Malignant Progression to Therapeutic Targeting: Current Insights of Mesothelin in Pancreatic Ductal Adenocarcinoma
por: Montemagno, Christopher, et al.
Publicado: (2020)

Therapeutic Status and Available Strategies in Pancreatic Ductal Adenocarcinoma
por: Thakur, Gitika, et al.
Publicado: (2021)

Hydrogel-Based Therapeutics for Pancreatic Ductal Adenocarcinoma Treatment
por: Liu, Jinlu, et al.
Publicado: (2023)

Locally Advanced Pancreatic Ductal Adenocarcinoma: Challenges and Progress
por: Barcellini, Amelia, et al.
Publicado: (2020)

F(1)F(0)-ATP Synthase Inhibitory Factor 1 in the Normal Pancreas and in Pancreatic Ductal Adenocarcinoma: Effects on Bioenergetics, Invasion and Proliferation
por: Tanton, Helen, et al.
Publicado: (2018)

Pancreatic Ductal Bicarbonate Secretion: Challenge of the Acinar Acid Load
por: Hegyi, Péter, et al.
Publicado: (2011)

Phosphoinositide regulation of inward rectifier potassium (Kir) channels
por: Fürst, Oliver, et al.
Publicado: (2014)

The EPH/Ephrin System in Pancreatic Ductal Adenocarcinoma (PDAC): From Pathogenesis to Treatment
por: Papadakos, Stavros P., et al.
Publicado: (2023)

The clinical relevance of the Hippo pathway in pancreatic ductal adenocarcinoma
por: Drexler, Richard, et al.
Publicado: (2020)

Calorie Restriction-Induced Increase in Skeletal Muscle Insulin Sensitivity Is Not Prevented by Overexpression of the p55α Subunit of Phosphoinositide 3-Kinase
por: Martins, Vitor F., et al.
Publicado: (2018)

MUC13 Interaction with Receptor Tyrosine Kinase HER2 Drives Pancreatic Ductal Adenocarcinoma Progression
por: Khan, Sheema, et al.
Publicado: (2016)

The Phosphoinositide 3-Kinase Pathway in Human Cancer: Genetic Alterations and Therapeutic Implications
por: Arcaro, Alexandre, et al.
Publicado: (2007)

The Emerging Role of Cyclin-Dependent Kinases (CDKs) in Pancreatic Ductal Adenocarcinoma
por: García-Reyes, Balbina, et al.
Publicado: (2018)

Protein Kinase D Regulates Cell Death Pathways in Experimental Pancreatitis
por: Yuan, Jingzhen, et al.
Publicado: (2012)

A rapid in vivo screen for pancreatic ductal adenocarcinoma therapeutics
por: Ocal, Ozhan, et al.
Publicado: (2015)

Pancreatic ductal adenocarcinoma in 2017: Time to change the therapeutic algorithm?
por: Crippa, Stefano, et al.
Publicado: (2017)

The Evolving Understanding of the Molecular and Therapeutic Landscape of Pancreatic Ductal Adenocarcinoma
por: Parkin, Ashleigh, et al.
Publicado: (2018)

Targets (Metabolic Mediators) of Therapeutic Importance in Pancreatic Ductal Adenocarcinoma
por: Rai, Vikrant, et al.
Publicado: (2020)

Small GTPases and phosphoinositides in the regulatory mechanisms of macropinosome formation and maturation
por: Egami, Youhei, et al.
Publicado: (2014)

Analysis of dynamic molecular networks for pancreatic ductal adenocarcinoma progression
por: Pan, Zongfu, et al.
Publicado: (2018)

Ion Channels Orchestrate Pancreatic Ductal Adenocarcinoma Progression and Therapy
por: Hofschröer, Verena, et al.
Publicado: (2021)

Role of the TRP Channels in Pancreatic Ductal Adenocarcinoma Development and Progression
por: Mesquita, Gonçalo, et al.
Publicado: (2021)

KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression
por: Zhang, Zining, et al.
Publicado: (2023)

The Role of Exosomes in Pancreatic Ductal Adenocarcinoma Progression and Their Potential as Biomarkers
por: Hsu, Sheng-Kai, et al.
Publicado: (2023)

Mimics of pancreatic ductal adenocarcinoma
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Pancreatic ductal adenocarcinoma staging
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Syndecans and Pancreatic Ductal Adenocarcinoma
por: Betriu, Nausika, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0at745iehe6tk4p114a1296f1i